SPRED1 deletion confers resistance to MAPK inhibition in melanoma

被引:19
作者
Ablain, Julien [1 ,2 ]
Liu, Sixue [3 ,5 ]
Moriceau, Gatien [3 ,5 ,6 ]
Lo, Roger S. [3 ,4 ,5 ,6 ]
Zon, Leonard, I [1 ,2 ,7 ,8 ]
机构
[1] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[7] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA
[8] Howard Hughes Med Inst, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
LEGIUS SYNDROME; PROTEIN; BRAF; DOMAIN; NF1; VEMURAFENIB; EFFICACY; MUTANTS; ENCODES; PATHWAY;
D O I
10.1084/jem.20201097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Functional evaluation of genetic lesions can discover a role in cancer initiation and progression and help develop novel therapeutic strategies. We previously identified the negative MAPK regulator SPRED1 as a novel tumor suppressor in KIT-driven melanoma. Here, we show that SPRED1 is also frequently deleted in human melanoma driven by mutant BRAF. We found that SPRED1 inactivation in human melanoma cell lines and primary zebrafish melanoma conferred resistance to BRAF(V600E) inhibition in vitro and in vivo. Mechanistically, SPRED1 loss promoted melanoma cell proliferation under mutant BRAF inhibition by reactivating MAPK activity. Consistently, biallelic deletion of SPRED1 was observed in a patient whose melanoma acquired resistance to MAPK-targeted therapy. These studies combining work in human cells and in vivo modeling in zebrafish demonstrate a new mechanism of resistance to BRAF(V600E) inhibition in melanoma.
引用
收藏
页数:14
相关论文
共 37 条
  • [1] Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma
    Ablain, Julien
    Xu, Mengshu
    Rothschild, Harriet
    Jordan, Richard C.
    Mito, Jeffrey K.
    Daniels, Brianne H.
    Bell, Caitlin F.
    Joseph, Nancy M.
    Wu, Hong
    Bastian, Boris C.
    Zon, Leonard I.
    Yeh, Iwei
    [J]. SCIENCE, 2018, 362 (6418) : 1055 - +
  • [2] A CRISPR/Cas9 Vector System for Tissue-Specific Gene Disruption in Zebrafish
    Ablain, Julien
    Durand, Ellen M.
    Yang, Song
    Zhou, Yi
    Zon, Leonard I.
    [J]. DEVELOPMENTAL CELL, 2015, 32 (06) : 756 - 764
  • [3] Genomic Classification of Cutaneous Melanoma
    Akbani, Rehan
    Akdemir, Kadir C.
    Aksoy, B. Arman
    Albert, Monique
    Ally, Adrian
    Amin, Samirkumar B.
    Arachchi, Harindra
    Arora, Arshi
    Auman, J. Todd
    Ayala, Brenda
    Baboud, Julien
    Balasundaram, Miruna
    Balu, Saianand
    Barnabas, Nandita
    Bartlett, John
    Bartlett, Pam
    Bastian, Boris C.
    Baylin, Stephen B.
    Behera, Madhusmita
    Belyaev, Dmitry
    Benz, Christopher
    Bernard, Brady
    Beroukhim, Rameen
    Bir, Natalie
    Black, Aaron D.
    Bodenheimer, Tom
    Boice, Lori
    Boland, Genevieve M.
    Bono, Riccardo
    Bootwalla, Moiz S.
    Bosenberg, Marcus
    Bowen, Jay
    Bowlby, Reanne
    Bristow, Christopher A.
    Brockway-Lunardi, Laura
    Brooks, Denise
    Brzezinski, Jakub
    Bshara, Wiam
    Buda, Elizabeth
    Burns, William R.
    Butterfield, Yaron S. N.
    Button, Michael
    Calderone, Tiffany
    Cappellini, Giancarlo Antonini
    Carter, Candace
    Carter, Scott L.
    Cherney, Lynn
    Cherniack, Andrew D.
    Chevalier, Aaron
    Chin, Lynda
    [J]. CELL, 2015, 161 (07) : 1681 - 1696
  • [4] Signatures of mutational processes in human cancer
    Alexandrov, Ludmil B.
    Nik-Zainal, Serena
    Wedge, David C.
    Aparicio, Samuel A. J. R.
    Behjati, Sam
    Biankin, Andrew V.
    Bignell, Graham R.
    Bolli, Niccolo
    Borg, Ake
    Borresen-Dale, Anne-Lise
    Boyault, Sandrine
    Burkhardt, Birgit
    Butler, Adam P.
    Caldas, Carlos
    Davies, Helen R.
    Desmedt, Christine
    Eils, Roland
    Eyfjord, Jorunn Erla
    Foekens, John A.
    Greaves, Mel
    Hosoda, Fumie
    Hutter, Barbara
    Ilicic, Tomislav
    Imbeaud, Sandrine
    Imielinsk, Marcin
    Jaeger, Natalie
    Jones, David T. W.
    Jones, David
    Knappskog, Stian
    Kool, Marcel
    Lakhani, Sunil R.
    Lopez-Otin, Carlos
    Martin, Sancha
    Munshi, Nikhil C.
    Nakamura, Hiromi
    Northcott, Paul A.
    Pajic, Marina
    Papaemmanuil, Elli
    Paradiso, Angelo
    Pearson, John V.
    Puente, Xose S.
    Raine, Keiran
    Ramakrishna, Manasa
    Richardson, Andrea L.
    Richter, Julia
    Rosenstiel, Philip
    Schlesner, Matthias
    Schumacher, Ton N.
    Span, Paul N.
    Teague, Jon W.
    [J]. NATURE, 2013, 500 (7463) : 415 - +
  • [5] THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS
    BALLESTER, R
    MARCHUK, D
    BOGUSKI, M
    SAULINO, A
    LETCHER, R
    WIGLER, M
    COLLINS, F
    [J]. CELL, 1990, 63 (04) : 851 - 859
  • [6] Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
    Beroukhim, Rameen
    Getz, Gad
    Nghiemphu, Leia
    Barretina, Jordi
    Hsueh, Teli
    Linhart, David
    Vivanco, Igor
    Lee, Jeffrey C.
    Huang, Julie H.
    Alexander, Sethu
    Du, Jinyan
    Kau, Tweeny
    Thomas, Roman K.
    Shah, Kinial
    Soto, Horacio
    Perner, Sven
    Prensner, John
    Debiasi, Ralph M.
    Demichelis, Francesca
    Hatton, Charlie
    Rubin, Mark A.
    Garraway, Levi A.
    Nelson, Stan F.
    Liau, Linda
    Mischel, Paul S.
    Cloughesy, Tim F.
    Meyerson, Matthew
    Golub, Todd A.
    Lander, Eric S.
    Mellinghoff, Ingo K.
    Sellers, William R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) : 20007 - 20012
  • [7] Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
    Bollag, Gideon
    Hirth, Peter
    Tsai, James
    Zhang, Jiazhong
    Ibrahim, Prabha N.
    Cho, Hanna
    Spevak, Wayne
    Zhang, Chao
    Zhang, Ying
    Habets, Gaston
    Burton, ElizabethA.
    Wong, Bernice
    Tsang, Garson
    West, Brian L.
    Powell, Ben
    Shellooe, Rafe
    Marimuthu, Adhirai
    Nguyen, Hoa
    Zhang, Kam Y. J.
    Artis, Dean R.
    Schlessinger, Joseph
    Su, Fei
    Higgins, Brian
    Iyer, Raman
    D'Andrea, Kurt
    Koehler, Astrid
    Stumm, Michael
    Lin, Paul S.
    Lee, Richard J.
    Grippo, Joseph
    Puzanov, Igor
    Kim, Kevin B.
    Ribas, Antoni
    McArthur, Grant A.
    Sosman, Jeffrey A.
    Chapman, Paul B.
    Flaherty, Keith T.
    Xu, Xiaowei
    Nathanson, Katherine L.
    Nolop, Keith
    [J]. NATURE, 2010, 467 (7315) : 596 - 599
  • [8] Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype
    Brems, Hilde
    Chmara, Magdalena
    Sahbatou, Mourad
    Denayer, Ellen
    Taniguchi, Koji
    Kato, Reiko
    Somers, Riet
    Messiaen, Ludwine
    De Schepper, Sofie
    Fryns, Jean-Pierre
    Cools, Jan
    Marynen, Peter
    Thomas, Gilles
    Yoshimura, Akihiko
    Legius, Eric
    [J]. NATURE GENETICS, 2007, 39 (09) : 1120 - 1126
  • [9] The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
    Ceol, Craig J.
    Houvras, Yariv
    Jane-Valbuena, Judit
    Bilodeau, Steve
    Orlando, David A.
    Battisti, Valentine
    Fritsch, Lauriane
    Lin, William M.
    Hollmann, Travis J.
    Ferre, Fabrizio
    Bourque, Caitlin
    Burke, Christopher J.
    Turner, Laura
    Uong, Audrey
    Johnson, Laura A.
    Beroukhim, Rameen
    Mermel, Craig H.
    Loda, Massimo
    Ait-Si-Ali, Slimane
    Garraway, Levi A.
    Young, Richard A.
    Zon, Leonard I.
    [J]. NATURE, 2011, 471 (7339) : 513 - +
  • [10] The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
    Cerami, Ethan
    Gao, Jianjiong
    Dogrusoz, Ugur
    Gross, Benjamin E.
    Sumer, Selcuk Onur
    Aksoy, Buelent Arman
    Jacobsen, Anders
    Byrne, Caitlin J.
    Heuer, Michael L.
    Larsson, Erik
    Antipin, Yevgeniy
    Reva, Boris
    Goldberg, Arthur P.
    Sander, Chris
    Schultz, Nikolaus
    [J]. CANCER DISCOVERY, 2012, 2 (05) : 401 - 404